Pituitary Diseases
Showing 1 - 25 of >10,000
Pituitary Adenoma Trial in Tainan (Endoscopic endonasal surgery)
Recruiting
- Pituitary Adenoma
- Endoscopic endonasal surgery
-
Tainan, TaiwanNational Cheng-Kung University Hospital
Nov 24, 2023
Surgical Outcomes and Complications.
Completed
- Pituitary Adenoma
- Surgery-Complications
-
Nancy, FranceCentre Hospitalier Régional Universitaire de Nancy
Sep 25, 2023
Long Term Outcome Study in Patients With Pituitary Disorders
Active, not recruiting
- Pituitary Diseases
- Pituitary Neoplasms
- (no location specified)
Jan 30, 2023
Pituitary Function After Recovery From Septic Shock Among ICU
Not yet recruiting
- Shock, Septic
- +2 more
-
Lucknow, UP, India
- +1 more
Aug 14, 2023
Imaging Features in Invasiveness and Prognosis of Pituitary
Recruiting
- Pituitary Adenoma
- Neuroendocrine Tumors
- diagnosed and treated reasonably according to the clinical guidelines and clinical pathways
-
Guangzhou, Guangdong, Chinaendocrinology department of the first affiliated hospital of Sun
Aug 24, 2023
Pituitary Trial in Modena
Not yet recruiting
- Pituitary
-
Modena, ItalyUnit of Endocrinology of Azienza Ospedaliero-Universitaria di Mo
Oct 26, 2022
Postoperative Pain Trial in Kocaeli (Dexmedetomidine, Remifentanyl)
Completed
- Postoperative Pain
-
Kocaeli, Izmit, TurkeyUniversity of Kocaeli
Mar 6, 2023
Cushing's Disease, Pituitary Adenoma Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Acthrel)
Not yet recruiting
- Cushing's Disease
- Pituitary Adenoma
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Adenoma Pituitary, CSF Leakage Trial (Bed rest)
Not yet recruiting
- Adenoma Pituitary
- CSF Leakage
- Bed rest
- (no location specified)
Dec 27, 2022
Healthy, Type 1 Diabetes Trial in Tartu (Placebo, Lixisenatide 10 micrograms (50 micrograms/ml in 3 ml) Pen Injector)
Not yet recruiting
- Healthy
- Type 1 Diabetes
- Placebo
- Lixisenatide 10 micrograms (50 micrograms/ml in 3 ml) Pen Injector
-
Tartu, EstoniaTartu University Hospital
Apr 7, 2023
DNA Methylation on the Invasiveness of Pituitary Tumors.
Recruiting
- Pituitary Tumors
- no interventions between two groups
-
Hanzhou, Zhejiang, China2ndAffiliated Hospital, School of Medicine
Dec 1, 2022
Pituitary Tumor Trial in Phoenix, Cleveland (Nasal saline irrigation)
Recruiting
- Pituitary Tumor
- Nasal saline irrigation
-
Phoenix, Arizona
- +1 more
Dec 19, 2022
Pituitary Adenoma Using Machine Learning
Recruiting
- Pituitary Neoplasms
- Artificial intelligence model
-
Shanghai, Shanghai, ChinaHuashan Hospital
Sep 28, 2022
Clinically Nonfunctioning Pituitary Adenomas
Recruiting
- Pituitary Adenoma
- Pituitary Tumor
- Surgical intervention for CNFA
- Radiotherapy for CNFA
-
New York, New YorkColumbia University Vagelos College of Physicians & Surgeons
Oct 24, 2022
Pituitary Stimulation Tests
Recruiting
- Pituitary
- Aging
- Pituitary stimulation test
-
Aalborg, Northen Jutland, DenmarkDepartment of Geriatric Medicine, Aalborg University Hospital
Sep 26, 2022
Acromegaly Due to Pituitary Adenoma Trial in Copenhagen (GIP-A, Placebo)
Recruiting
- Acromegaly Due to Pituitary Adenoma
- GIP-A
- Placebo
-
Copenhagen, DenmarkDepartment of Biomedical Sciences
Nov 1, 2022
Pituitary Adenoma Invasive, Nasal Obstruction Trial in Ostrava (Nasal patency - rhinomanometry, Nasal patency - nasal
Not yet recruiting
- Pituitary Adenoma Invasive
- Nasal Obstruction
- Nasal patency - rhinomanometry
- Nasal patency - nasal inspiratory peak flow
-
Ostrava, Moravian-Silesian Region, CzechiaUniversity Hospital Ostrava
Jun 16, 2023
Hypotalamic-pituitary Region of Metabolic Syndrome and Obesity
Completed
- Overweight and Obesity
- Metabolic Syndrome
- Bariatric surgery
- Diet and lifestyle changes
-
Rome, ItalyAndrea M Isidori
Dec 4, 2022
Genetics of Endocrine Tumours - Familial Isolated Pituitary
Recruiting
- Acromegaly
- +5 more
-
London, United Kingdom
- +1 more
Oct 17, 2022
Defining Genetic Basis for Development of Primary Pigmented
Completed
- Cushing's Syndrome
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 18, 2023
Recurrent Pituitary Adenomas Trial in New York (Capecitabine, Temozolomide)
Terminated
- Recurrent Pituitary Adenomas
-
New York, New YorkWeill Cornell Medical College
Jul 15, 2022
Pituitary Adenoma Trial in Nantong (Excision of pituitary tumor outside pseudocapsule)
Not yet recruiting
- Pituitary Adenoma
- Excision of pituitary tumor outside pseudocapsule
-
Nantong, Jiangsu, ChinaAffiliated Hospital of Nantong University
Jul 19, 2022
Pituitary Macroadenoma Trial in Lebanon (intra-operative MRI, Transsphenoidal resection of pituitary macroadenoma)
Suspended
- Pituitary Macroadenoma
- intra-operative MRI
- Transsphenoidal resection of pituitary macroadenoma
-
Lebanon, New HampshireDartmouth Hitchcock Medical Center
Jul 15, 2022